BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy

Core Viewpoint - BioHarvest Sciences Inc. announces the resignation of Mr. David Tsur from its Board of Directors after over four years, and the appointment of Prof. Hezi Levy to the Board, effective immediately [1][2]. Group 1: Board Changes - Mr. David Tsur has been a member of BioHarvest's Board since 2021, contributing significantly to the company's strategic development during a period of operational expansion and product commercialization [2]. - Chairman Zaki Rakib expressed gratitude for Mr. Tsur's leadership and contributions, highlighting his role in supporting the company's growth and strategic evolution [3]. - Prof. Hezi Levy brings decades of leadership experience in Israel's healthcare system, having previously served as Director General of the Israeli Ministry of Health and played a key role during the COVID-19 pandemic [3][4]. Group 2: Prof. Hezi Levy's Background - Prof. Levy has extensive experience, including serving as Head of the Medical Corps of the Israel Defense Forces (IDF) and General Manager of Barzilai Medical Center, overseeing major healthcare operations [4]. - His medical expertise and executive leadership are expected to strengthen BioHarvest's governance as the company scales its direct-to-consumer products and advances its biotechnology CDMO platform [5]. Group 3: Company Overview - BioHarvest is a leader in Botanical Synthesis, utilizing patented technology to grow plant-based compounds without the need for the underlying plants [5]. - The company focuses on developing science-based therapeutic solutions in two main areas: as a contract development and production organization (CDMO) and as a creator of proprietary nutraceutical health and wellness products [5].